Home›Companies›Healthcare›ThetaRho

ThetaRho, Inc.

Sells on-site AI systems for clinical research teams.

Updated Nov 10, 2026·Latest SEC filing Apr 24, 2026·Suggest an edit

About ThetaRho

ThetaRho is a private company based in Santa Clara, California, incorporated in 2023 in Delaware. It has reported $900,000 raised in two offerings on Form D since December 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 7, 2025May 5, 2025amended Apr 24, 2026$750,000of $1.5M target8$93,750Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Dec 19, 2023Dec 26, 2023$150,000of $2.0M target2$75,000Options, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$900,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ThetaRho's Form D filed Apr 24, 2026.

Ramani Narayan
Ramani Narayan
Executive Officer and Director
Kannan Govindarajan
Kannan Govindarajan
President and director

Sources

  1. SECThetaRho, Inc. Form D, filed May 5, 2025
  2. SECThetaRho, Inc. filing history
  3. CompanyAbout ThetaRho
  4. CompanyContact ThetaRho